Analysis of small cell lung cancer (SCLC) patients (Pts) treated on cancer therapy evaluation program (CTEP)-sponsored phase I trials: 1992-2012.

被引：0
|
作者：
Forde, Patrick M.
Hooker, Craig M.
Rubinstein, Larry
Hann, Christine L.
Harris, Pamela Jo
机构：
[1] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
[2] Biometr Res Branch, Bethesda, MD USA
[3] NCI, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.7524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7524
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Analysis of Lung Cancer Patients Enrolled in CTEP (Cancer Therapy Evaluation Program)-Sponsored Phase I Trials
    Gadgeel, Shirish M.
    Ivy, Percy
    Chen, Wei
    Mauer, Joan
    Smith, Daryn
    LoRusso, Patricia
    CLINICAL LUNG CANCER, 2011, 12 (04) : 218 - 223
  • [2] Analysis of esophagogastric cancer patients enrolled in National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP)-sponsored phase I trials
    Bando, Hideaki
    Rubinstein, Larry
    Harris, Pamela Jo
    Yoshino, Takayuki
    Doi, Toshihiko
    Ohtsu, Atsushi
    Welch, Jack
    Takebe, Naoko
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [3] Characteristics and outcome of breast cancer patients enrolled in cancer therapy evaluation program (CTEP) sponsored phase I clinical trials
    Lynce, Filipa
    Rubinstein, Larry
    Harris, Pamela
    CANCER RESEARCH, 2015, 75
  • [4] Phase I study of amrubicin (AMR) for patients (pts) with previously treated small cell lung cancer (SCLC)
    Katakami, N.
    Hata, A.
    Yoshioka, H.
    Higashi, Y.
    Nishimura, T.
    Sakaguchi, S.
    Hayashi, M.
    Tomii, K.
    Naya, R.
    Ishihara, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Small cell lung cancer (SCLC): Analysis of 334 consecutive patients (pts)
    Fiorio, E.
    Genestreti, G.
    Tassinari, D.
    Papi, M.
    Tamburini, E.
    Pasquini, E.
    Ravaioli, A.
    Giovannini, M.
    Cetto, G. L.
    Santo, A.
    ANNALS OF ONCOLOGY, 2005, 16 : 28 - 28
  • [6] A phase I study of weekly oral topotecan in patients (pts) with relapsed small cell lung cancer (SCLC)
    Kontopodis, E.
    Vamvakas, L.
    Kalbakis, K.
    Vardakis, N. K.
    Sfakiotaki, G.
    Georgoulias, V.
    Agelaki, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Prognostic factors for 90-day mortality in patients with solid malignancies treated on Phase 1 trials sponsored by the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute.
    Wong, Kit Man
    Rubinstein, Larry
    Rinker, Matthew
    Smith, Gary Lee
    Sharon, Elad
    Eckhardt, S. Gail
    Messersmith, Wells A.
    Leong, Stephen
    Harris, Pamela Jo
    Gao, Dexiang
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trials
    Bando, Hideaki
    Rubinstein, Larry
    Harris, Pamela
    Yoshino, Takayuki
    Doi, Toshihiko
    Ohtsu, Atsushi
    Welch, John
    Takebe, Naoko
    GASTRIC CANCER, 2017, 20 (03) : 481 - 488
  • [9] Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trials
    Hideaki Bando
    Larry Rubinstein
    Pamela Harris
    Takayuki Yoshino
    Toshihiko Doi
    Atsushi Ohtsu
    John Welch
    Naoko Takebe
    Gastric Cancer, 2017, 20 : 481 - 488
  • [10] Tarlatamab for patients (pts) with previously treated small cell lung cancer (SCLC): Primary analysis of the phase II DeLLphi-301 study
    Paz-Ares, L.
    Ahn, M-J.
    Felip, E.
    Handzhiev, S.
    Korantzis, I.
    Izumi, H.
    Ohashi, K.
    Majem, M.
    Wolf, J.
    Reck, M.
    Hummel, H-D.
    Blackhall, F.
    Dingemans, A-M. C.
    Owonikoko, T. K.
    Ramalingam, S. S.
    Sands, J.
    Jiang, T.
    Mukherjee, S.
    Anderson, E.
    Cho, B. C.
    ANNALS OF ONCOLOGY, 2023, 34 : S1333 - S1334
12345